KEYNOTE-173: Phase 1b multicohort study of pembrolizumab (Pembro) in combination with chemotherapy as neoadjuvant treatment for triple-negative breast cancer (TNBC)

被引：13
|
作者：
Schmid, P.
Park, Y. H.
Munoz-Couselo, E.
Kim, S-B
Sohn, J.
Im, S-A
Holgado, E.
Foukakis, T.
Kuemmel, S.
Dent, R.
Yin, L.
Ding, Y.
Tryfonidis, K.
Cortes, J.
机构：
[1] Barts Canc Inst, Ctr Med Expt, London, England
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[3] Vall dHebron Inst Oncol VHIO, Barcelona, Spain
[4] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Seoul, South Korea
[6] Seoul Natl Univ, Coll Med, Seoul, South Korea
[7] Ramon y Cajal Univ Hosp, Madrid, Spain
[8] Karolinska Univ Hosp, Radiumhemmet, Stockholm, Sweden
[9] Kliniken Essen Mitte, Essen, Germany
[10] Natl Canc Ctr, Singapore, Singapore
[11] Merck & Co Inc, Kenilworth, NJ USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-PD5-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD5-01
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A phase II, randomized, open-labeled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC)
    Arora, Adhip
    Seenu, V.
    Parshad, Rajinder
    Bansal, V. K.
    Dhar, Anita
    Mathur, Sandeep
    Tanwar, Pranay
    Mishra, Piyush
    Kataria, Kamal
    Gogia, Ajay
    Kumar, Brijesh
    Haresh, K. P.
    Mallick, Supriya
    Saini, Surendra Kumar
    Mishra, Ashutosh
    Bansal, Babul
    Sharma, Jyoti
    Saikia, Jyoutishman
    Rangarajan, Krithika
    Dhamija, Ekta
    Prasad, Chandra Prakash
    Shamin, Shamim Ahmed
    Agastm, Sourabh
    Kalra, Kaushal
    Vishvam, Divvay
    Mani, Kalaivani
    Kumar, Akash
    Bakhshi, Sameer
    Batra, Atul
    TRIALS, 2025, 26 (01)
  • [22] Real-world comparison: Neoadjuvant pembrolizumab (pembro-NACT) vs. dose-dense neoadjuvant chemotherapy (ddNACT) in early stage triple-negative breast cancer (TNBC)
    Barbi, Mali
    Noel, Jovanka
    Lee, Chung-Shien
    Rahman, Husneara
    Cheng, Kit
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Clinical and biomarker results of neoadjuvant phase II study of pembrolizumab and carboplatin plus docetaxel in triple-negative breast cancer (TNBC) (NeoPACT).
    Sharma, Priyanka
    Stecklein, Shane Richard
    Yoder, Rachel
    Staley, Joshua M.
    Schwensen, Kelsey
    O'Dea, Anne
    Nye, Lauren Elizabeth
    Elia, Manana
    Satelli, Deepti
    Crane, Gregory
    Madan, Rashna
    O'Neil, Maura F.
    Wagner, Jamie L.
    Larson, Kelsey E.
    Balanoff, Christa
    Phadnis, Milind A.
    Godwin, Andrew K.
    Salgado, Roberto
    Khan, Qamar J.
    O'Shaughnessy, Joyce
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] A Phase I Trial of Talimogene Laherparepvec in Combination with Neoadjuvant Chemotherapy for the Treatment of Nonmetastatic Triple-Negative Breast Cancer
    Soliman, Hatem
    Hogue, Deanna
    Han, Hyo
    Mooney, Blaise
    Costa, Ricardo
    Lee, Marie C.
    Niell, Bethany
    Williams, Angela
    Chau, Alec
    Falcon, Shannon
    Khakpour, Nazanin
    Weinfurtner, Robert J.
    Hoover, Susan
    Kiluk, John
    Rosa, Marilin
    Khong, Hung
    Czerniecki, Brian
    CLINICAL CANCER RESEARCH, 2021, 27 (04) : 1012 - 1018
  • [25] Efficacy and safety of neoadjuvant chemotherapy combination with pembrolizumab in triple-negative breast cancer: Real-world data
    Rached, L. W.
    Spotti, M. P.
    Baldini, C.
    Laparra, A.
    Remote, C. A. Dutertre
    Sakkal, M.
    Perret, A.
    Viansone, A. A.
    Zeghondy, J. Z.
    Rassy, E.
    Bousrih, C.
    Abdayem, P.
    Abboud, R. M. Khoury
    El Masri, H. K.
    Grinda, T.
    Terencio, S. Moragon
    Verret, B.
    Champiat, S.
    Pistilli, B.
    Ribeiro, J. T. M. L.
    ANNALS OF ONCOLOGY, 2023, 34 : S288 - S288
  • [26] Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
    Nanda, Rita
    Chow, Laura Q. M.
    Dees, E. Claire
    Berger, Raanan
    Gupta, Shilpa
    Geva, Ravit
    Pusztai, Lajos
    Pathiraja, Kumudu
    Aktan, Gursel
    Cheng, Jonathan D.
    Karantza, Vassiliki
    Buisseret, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (21) : 2460 - +
  • [27] Phase II study of Pembrolizumab Maintenance treatment in patients with HER2-negative inflammatory breast cancer (IBC) and triple-negative breast cancer (TNBC) after response to chemotherapy
    Iwase, Toshiaki
    Alexander, Angela
    Chiv, Vivian
    Kai, Megumi
    Kida, Kumiko
    Parker, Charla
    Marx, Angela N.
    Cohen, Evan
    Gao, Hui
    Reuben, James
    Wang, Xiaoping
    Krishnamurthy, Savitri
    Liu, Diane
    Shen, Yu
    Ramirez, David
    Tripathy, Debu
    Booser, Daniel
    Yam, Clinton
    Valero, Vicente
    Lim, Bora
    Ueno, Naoto T.
    Willey, Jie S.
    CANCER RESEARCH, 2023, 83 (05)
  • [28] Design of a phase 1b/2 study to evaluate the efficacy and safety of eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer
    Berrak, E.
    Atkan, G.
    Song, J.
    Almonte, A.
    Karantza, V.
    Yuan, R.
    CANCER RESEARCH, 2016, 76
  • [29] Pre-operative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)
    McArthur, Heather
    Shiao, Stephen
    Karlan, Scott
    Basho, Reva
    Amersi, Farin
    Arnold, Brittany
    Burnison, Michele
    Chung, Alice
    Chung, Cathie
    Dang, Catherine
    Giuliano, Armando
    Kapoor, Nimmi
    Khameneh, Negin Habibi
    Knott, Simon
    Martin, Cynthia
    McAndrew, Philomena
    Mita, Monica
    Park, Dorothy
    Abaya, Christina DiLauro
    Ho, Alice
    CANCER RESEARCH, 2021, 81 (04)
  • [30] Pre-operative pembrolizumab (pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)
    McArthur, Heather
    Shiao, Stephen
    Karlan, Scott
    Amersi, Farin
    Arnold, Brittany
    Basho, Reva
    Burnison, Michele
    Chung, Alice
    Chung, Cathie
    Dang, Catherine
    Giuliano, Armando
    Khameneh, Negin Habibi
    Knott, Simon
    Martin, Cynthia
    McAndrew, Philomena
    Mita, Monica
    Park, Dorothy
    Abaya, Christina
    Ho, Alice
    CANCER RESEARCH, 2020, 80 (04)
12345